Campbell & Co Investment Adviser’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-1,215
| Closed | -$565K | – | 1396 |
|
|
2024
Q3 | $565K | Sell |
1,215
-288
| -19% | -$134K | 0.04% | 659 |
|
|
2024
Q2 | $704K | Buy |
1,503
+509
| +51% | +$239K | 0.06% | 514 |
|
|
2024
Q1 | $416K | Sell |
994
-4,394
| -82% | -$1.84M | 0.04% | 783 |
|
|
2023
Q4 | $2.19M | Buy |
5,388
+3,206
| +147% | +$1.3M | 0.2% | 109 |
|
|
2023
Q3 | $759K | Buy |
2,182
+764
| +54% | +$266K | 0.09% | 365 |
|
|
2023
Q2 | $499K | Buy |
1,418
+187
| +15% | +$65.8K | 0.09% | 439 |
|
|
2023
Q1 | $388K | Sell |
1,231
-2,829
| -70% | -$891K | 0.07% | 512 |
|
|
2022
Q4 | $1.17M | Buy |
+4,060
| New | +$1.17M | 0.28% | 71 |
|
|
2021
Q4 | – | Sell |
-1,900
| Closed | -$345K | – | 837 |
|
|
2021
Q3 | $345K | Buy |
+1,900
| New | +$345K | 0.11% | 328 |
|